Order Entry
Puerto Rico
ContactUsLinkComponent
RF IgA (Rheumatoid Factor) ELISA, Eagle Biosciences, Inc.
RF IgA (Rheumatoid Factor) ELISA, Eagle Biosciences, Inc.
Catalog # 102993-788
Supplier:  Eagle Biosciences
CAS Number:  
RF IgA (Rheumatoid Factor) ELISA, Eagle Biosciences, Inc.
Catalog # 102993-788
Supplier:  Eagle Biosciences
Supplier Number:  4027
CAS Number:  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/us/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

Specifications

  • Description:
    RF IgA (Rheumatoid Factor) ELISA
  • Size:
    1 kit
  • Cat. No.:
    102993-788
  • Supplier no.:
    RFA31-K01

Specifications

About this item

RF IgA ELISA is used to detect rheumatoid factor (RF) IgA autoantibodies in human serum or plasma.

  • Dynamic Range: 1-300 U/mL
  • Sensitivity: 1 U/mL
  • Incubation: 2.5 hours

Patients suffering from rheumatoid arthritis (RA) exhibit RF autoantibodies recognizing the Fc part of IgG. RA or chronic polyarthritis has a yet unknown etiology and represents the most frequent rheumatic inflammatory disorder demonstrating a prevalence of up to 1%.  One of the typical manifestations of RA is symmetric synovialitis of limb joints often accompanied by involvement of the cervical spinal column. Beside clinical features one of the criteria of the American College of Rheumatology for the classification of RA is the presence of RF (1). Up to 80 % of RA patients may demonstrate RF. RF can occur years prior to the onset of disease and RF positive apparently healthy individuals bear a 5 - 40 times higher risk to develop RA (2). However, patients suffering from other autoimmune, infectious or B-cell lympho¬pro-liferative disorders as well as apparently healthy elderly individuals may develop RF. High concentrations of RF are often associated with a more severe disease comprising a faster destruction of joints. In addition, they are found in patients with extra-articular manifestations such as rheumatoid nodules, polyneuropathy, vasculitis or Sicca syndrome. RF may belong to the IgG, IgM or IgA isotype whereas IgM RF is the most frequent isotype to be determined in RA patients. Extra-articular manifestations seem to be associated with IgA RF. Like RF of the IgM isotype high concentrations of IgG RF seems to appear with patients suffering from more progressive erosions of joints. In long- time RA IgA and IgG RF are considered to be prognostic markers for systemic manifestation.